USSTOCK.TODAY
Market Closed
Log in Sign up

Arrowhead Pharmaceuticals shares fall 2.4% in Thursday after-hours trading on earnings miss

Investing.com +1 · ·by G4L

ARWR
ARWR Arrowhead Pharmaceuticals Inc
$47.15 -4.48%
View chart & analysis →
  1. 1Arrowhead Pharmaceuticals Inc reported total revenue of $450.82 million for fiscal year 2026, missing market expectations.
  2. 2Arrowhead Pharmaceuticals Inc reported an adjusted loss per share of $5.11 for the fiscal year ended September 30, 2026.
  3. 3Arrowhead Pharmaceuticals Inc shares fell 2.4% in Thursday after-hours trading.

So what's the key point?

Arrowhead Pharmaceuticals Inc reported total revenue of $450.82 million for fiscal year 2026, which was below market expectations.

Source Investing.com +1 · View original ↗

Related 3-line summaries

Arrowhead Pharmaceuticals shares rise 6.7% on Alzheimer's treatment clinical data release Investing.com +2 · Oct 15Arrowhead Pharma target price raised on plozasiran clinical win; shares jump 19% Stocktwits +3 · Jul 24Arrowhead shares jump 18% on Phase 3 success of plozasiran InvestorsHub +1 · Jul 24
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news